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Abstract—Photoreceptors are light-sensitive cells in the retina converting visual stimuli into electrochemical sig-
nals. These signals are evaluated and interpreted in the visual pathway, a process referred to as visual process-
ing. Phosphodiesterase type 5 and 6 (PDE5 and 6) are abundant enzymes in retinal vessels and notably
photoreceptors where PDE6 is exclusively present. The effects of the PDE inhibitor sildenafil on the visual sys-
tem, have been studied using electroretinography and a variety of clinical visual tasks. Here we evaluate effects
of sildenafil administration by electrophysiological recordings of flash visual evoked potentials (VEPs) and
steady-state visual evoked potentials (SSVEPs) from key regions in the rodent visual pathway. Progressive
changes were investigated in female Sprague-Dawley rats at 10 timepoints from 30 min to 28 h after peroral
administration of sildenafil (50 mg/kg). Sildenafil caused a significant reduction in the amplitude of VEPs in both
visual cortex and superior colliculus, and a significant delay of the VEPs as demonstrated by increased latency of
several VEP peaks. Also, sildenafil-treatment significantly reduced the signal-to-noise ratio of SSVEPs. The
effects of sildenafil were dependent on the wavelength condition in both assays. Our results support the obser-
vation that while PDE6 is a key player in phototransduction, near full inhibition of PDE6 is not enough to abolish
the complex process of visual processing. Taken together, VEPs and SSVEPs are effective in demonstrating pro-
gressive effects of drug-induced changes in visual processing in rats and as the same paradigms may be applied
in humans, representing a promising tool for translational research.  2020 The Author(s). Published by Elsevier Ltd on
behalf of IBRO. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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INTRODUCTION
Photoreceptors are critical for light detection in the retina.
The transduction of light into a neural signal occurs in the
outer segment of the photoreceptors. During this process,
photons excite light-sensitive G-protein coupled receptor
proteins called rhodopsins, activating a retina-specific
phosphodiesterase type 6 (PDE6) (Wert et al., 2014),
which hydrolyzes cyclic guanosine monophosphate
(cGMP) causing closure of sodium channels in the outer
segment, hyperpolarizing the photoreceptor. This triggers
a cascade of cellular processes transforming the light
signal into electrochemical signals that are propagated
to post-synaptic neurons (Sawinski et al., 2009).
Retinal ganglion cells (RGCs) and especially the
intrinsically photosensitive (ipRGCs) are also involved in
transduction of light in the rat visual pathways. The
ipRGCs are implicated in triggering light-induced
reflexes such as pupillary constriction and regulation of
the circadian rhythm (Reifler et al., 2015; Jiang et al.,
2018). The exact mechanism of photoreception in
ipRGCs is not fully elucidated but previous studies pro-
pose involvement of the photopigment melanopsin
through cGMP-independent and thus PDE-independent
mechanisms (Warren et al., 2006; Jiang et al., 2018).
The ipRGCs project to cardinal relays of visual cortex in
mice and rats, i.e. the dorsolateral geniculate nucleus,
but whether they exist in higher order mammals remains
to be elucidated (Reifler et al., 2015).
Sildenafil citrate (henceforth, ‘sildenafil’) is a PDE
inhibitor which mainly targets PDE5. Sildenafil also
inhibits PDE6, but with a 10-fold lower efficacy
(Wallis, 1999). Sildenafil (marketed as Viagra among
others) is generally well tolerated but some patients expe-
rience temporary visual impairments such as changes in
color discrimination (Laties and Zrenner, 2002;
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Martins et al., 2015), blue color tinge to vision, transient
blindness and reductions in the amplitude of electroretino-
grams (ERGs) (Vobig et al., 1999; Ja¨gle et al., 2004). Due
to the localization of PDE6 in the internal membranes of
retinal photoreceptors (Cote, 2004) and bipolar cells
(Shiells and Falk, 2002; Moschos and Nitoda, 2016),
these visual disturbances have been ascribed to inhibition
of PDE6. Inhibition of PDEs increases cytoplasmic levels
of cGMP (Loughney and Ferguson, 1996) preventing
hyperpolarization of the outer segment of the photorecep-
tors (Wert et al., 2014). Furthermore, sildenafil is a
hypotensive agent causing decreases in systemic blood
pressure temporarily increasing the intraocular blood
pressure (Gerometta et al., 2011). This effect has been
associated with reductions in retinal electrical potentials
as measured by ERG (Bui et al., 2005).
Sildenafil has been used to investigate retinal PDE6
function in both humans (reviewed in Laties and
Zrenner, 2002), monkeys (Kinoshita et al., 2015), dogs
(Wallis, 1999) and rodents (Wallis et al., 1999; Nivison-
Smith et al., 2014). But PDE6 inhibitors are not the only
source for evaluation of functional effects of deficient
PDE6 function. Several severe retinopathies, like achro-
matopsia and retinitis pigmentosa, may be caused by
mutations in genes encoding PDE6 (Zhang et al., 2005;
Heckenlively and Arden, 2006; Gopalakrishna et al.,
2017) and diseases impacting retinal function represent
some of the most common forms of neurodegenerative
disorders (Hartong et al., 2006; He et al., 2014). Conse-
quently, these patient populations, and recent murine
models (Nivison-Smith et al., 2014), have contributed to
the current knowledge on the association between
PDE6 and the visual pathway.
The transient or flash visual evoked potential (VEP) is
an event-related potential (ERP) representing net
changes in post-synaptic electrical potentials as a
response to sensory stimulations. The VEP is
considered to be a measure of neurological integrity of
the visual pathway (Iwamura et al., 2003; You et al.,
2011). Steady-state visual evoked potentials (SSVEP)
are VEPs evoked by high frequency stimuli presumably
causing a summation of the VEPs (Vialatte et al., 2010).
SSVEPs are most appropriately analyzed in the frequency
domain by a Fourier transform yielding information about
the amplitude and the phase of the evoked potential
(Regan, 1989; Luck, 2005; Norcia et al., 2015). As
opposed to VEPs, it has been proposed that SSVEPs
may enable differentiation between different cell types in
the retina. These observations are based on recordings
of visual evoked potentials in Drosophila. Here, photore-
ceptors are shown to respond to the frequency of the stim-
ulus while second lamina cells (invertebrate RGCs) seem
to respond at double rate corresponding to the second har-
monic (Afsari et al., 2014). Whether this interpretation is
also applicable for rodents remains to be elucidated.
In rodents, the superior colliculus is the major
retinorecipient nucleus and the visual evoked potential
here is comparable to responses obtained by ERG
(Sefton et al., 2014). The rodent visual cortex receives
visual information relayed from different nuclei and
diverse parts of the brain, but no direct signal from the
retina (Sefton et al., 2014). Consequently, we chose to
record from these anatomical areas. Some types of RGCs
have been shown to be sensitive to light in the blue part of
the spectrum (Panda et al., 2005; Baden et al., 2016;
Lagman et al., 2016). Thus, stimuli with wavelengths
overlapping these spectra were used to probe the contri-
bution of different cell types (photoreceptors vs RGCs) to
the evoked signal. Surprisingly, no study has yet used
electroencephalography (EEG) to characterize visual
effects of sildenafil in either clinical or preclinical studies
although this technique has a high translational potential.
Consequently, we investigated rodent electrophysiologi-
cal responses during visual processing by characteriza-
tion of flash VEPs and SSVEP recorded from the
superior colliculus and the visual cortex. We studied
how net electrophysiological activity changed over time
following administration of sildenafil and thus PDE6 inhibi-
tion, thereby modelling progressive changes in retinal
PDE6 function.
EXPERIMENTAL PROCEDURES
All animal experimentation was carried out according to
European Communities Council Directive (86/609/EEC)
and Danish legislation on care for laboratory animals.
Animals
Eight Sprague Dawley (SD) female rats (Taconic,
Denmark) weighing 225 g on arrival, were kept on a
reversed 12 h circadian cycle (lights on at 18:00 h).
They were single housed in Makrolon type IV cages
with wood bedding, food and water ad libitum. The
cages were enriched with food enrichment (once a
week), a red house, nesting material and wood for
gnawing. The temperature in the housing room, was set
at 22 ± 1.5 C and the humidity at 55–65%.
Surgery
The animals were anesthetized using subcutaneous (SC)
injections of Hypnorm (Lundbeck, Valby, Denmark),
midazolam 5 mg/ml (B.Braun, Melsungen, Germany)
and saline in a 2:1:1 relation (2.0 ml/kg), yielding
157 mg/kg fentanyl. Norodyl (carprofen 5 mg/kg)
(ScanVet, Fredensborg, Denmark) and Noromox
prolongatum (amoxicillintrihydrate 150 mg/kg) (ScanVet,
Fredensborg, Denmark) were administered during
surgery and for five days post-surgery. The animals
were mounted in a stereotactic frame and Marcain
(2.5 mg/ml bupivacaine, AstraZeneca, Albertslund,
Denmark), was administered locally (SC) prior to
incision. Coordinates were guided by Paxinos and
Watson (1998) and are given in millimeters relative to
bregma, AP are the anterior–posterior axis, ML are the
medial–lateral axis. The depth is given in DV the
dorsal–ventral axis. Holes were drilled bilaterally for
implantation of recording electrodes in visual cortex
(AP: 6, ML: ±4) and superior colliculus (AP: 6, ML:
±1, DV: 3.5). A reference electrode (AP: +8, ML:
2) and a ground electrode (AP: 2, ML: +4) were also
implanted. The electrodes for recording in the superior
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colliculus were stranded electrodes E363/3/Spc (Plas-
ticsOne, VA, US). The other four electrodes were
E363/20/2.4/S screw electrodes (PlasticsOne). The elec-
trodes were collected in a plastic pedestal MS363 (Plas-
ticsOne) and fixed to the skull with RelyXTM Unicem
dental cement (3M, Copenhagen, Denmark) and Fuji plus
cement (GC America, US) as a chronic implant. The ani-
mals were allowed to recover for 14 days before initiation
of experiments.
EEG recording
The recordings weremade during the dark phase in awake
and behaving animals in a Makrolon type IV cage with
wood bedding. The LEDs were positioned in a frame
40 cm above the bedding. First, a 30 min baseline
recording was obtained from the rats while the visual
stimulation paradigms were presented. Following
administration of sildenafil, the same type of recordings
was made every 30 min for the first two hours, then after
4, 5, 7, 24 and 28 h, in total ten recordings per animal.
The animals were exposed to whole-field light flashes
of 20 lx white LED (390–700 nm, SMD5050), 20 lx blue
(455–460 nm), and 5 lx short wave blue (SWB) (405 nm).
Each flash had a duration of 10 ms and 400 flashes were
applied at a frequency of 1 Hz to record flash VEPs. Then,
the frequency was increased to 14 Hz and the SSVEPs
were recorded for 100 s. Light stimulation was controlled
by Spike2 software version 7.20 (Cambridge Electronic
Design Ltd, Cambridge, UK). Spike2 was also used for
recording of the EEG signals. Signals were amplified
and filtered using a Brownlee amplifier model 410
(Brownlee Precision, CA, US) at the following settings:
low-pass filter; 200 Hz, high-pass filter; 1 Hz, sampling
rate; 1000 Hz. EEG recordings were carried out in four
animals, while the exposure data included eight rats.
Drug administration, pharmacokinetic
characterization and histology
The rats received sildenafil citrate extracted from Viagra
(Pfizer, NY, US) 50 mg/kg in 0.1 M HCl, pH adjusted to 4
with NaOH (Abbott et al., 2004). The solution was admin-
istered perorally. The rats were chosen based on visual
inspection of the VEP (pilot data, not shown) recorded
in the superior colliculus.
The rats were sacrificed 15 min (n= 4) or 5 h (n= 4)
after drug administration (Walker et al., 1999). Trunk
blood was sampled, and the cerebellum was harvested
and weighed for exposure profiling of sildenafil. The cere-
brum was removed and snap frozen on dry ice and used
for validating the location of the electrodes. The brains
were sliced in a freeze microtome in 20 mm thick coronal
slices and placed directly on glass slides for microscopy
inspection. Although the electrodes were removed before
the cerebrum was snap frozen they left visible traces in
the tissue.
Exposure
The cerebellum was thawed and homogenized using a
Covaris 220X (Covaris Inc., MA, US). The concentration
of sildenafil was quantified in a LC–MS/MS platform
(Xevo TQS triple quadrupole) mass spectrometer
operated in electrospray MS/MS mode (multiple reaction
mode) and coupled to a Waters Acquity UPLC
controlled by MassLynx software version 4.1 (Waters,
MA, US). Mass spectrometry methods yielded the total
concentration of sildenafil in the tissue samples. The
free fraction of sildenafil in blood and brain was
determined as previously described in (Bundgaard et al.,
2012). The free fractions of sildenafil were 7.2% and
3.9% in the blood and brain, respectively. These values
were used to calculate the unbound concentrations of
sildenafil in the samples.
Data analysis and statistics
The flash VEPs were generated by averaging single
sweeps time-locked to the visual stimuli from 0.2 s to
+0.5 s relative to stimulation offset using Spike2. Grand
averages were created and VEP peaks were quantified.
Naming of the peaks in the visual cortex was guided by
(Creel et al., 1974; Meeren et al., 1998). The first positive
deflection was named P1, the first negative deflection is
named N1, the second positive deflection is named P2
and so on. For flash VEPs, the amplitude (i.e. from base-
line to peak measured in mV) and latency (i.e. from stim-
ulus onset to peak measured in s) of the different peaks
were analyzed separately.
The overall effect of sildenafil was assessed by two-
way ANOVA, testing the effect of time and wavelength
condition using R via the open source software Rstudio.
The three wavelength conditions were analyzed
separately, and analysis was carried out on four
timepoints as the temporal resolution of the effect of
sildenafil is quite low (i.e., baseline, 0.5, 5 and 28 h).
These four timepoints were chosen from visual inspection
and PK/PD from a previous study suggesting that the
maximum plasma concentration of sildenafil in female
rats is Tmax= 15 min and a half-life of 1 h (Walker et al.,
1999). Separate ANOVAs were computed for the latency
and amplitude of each peak, yielding 72 one-way ANOVAs
testing the variance over time (DF = 3). These were fol-
lowed by Tukey post-hoc tests, when the level of signifi-
cance was p< 0.05. The p-values were adjusted for
multiple comparisons using the false discovery rate
(FDR) method (Benjamini and Yekutieli, 2001).
The SSVEP were analyzed using a custom-made
script programmed in Matlab 2016a (Mathworks, MA,
USA) fitting sinusoids to determine amplitude by
applying a fast Fourier transform. To test for an effect of
sildenafil, the signal-to-noise ratios (SNRs) of the
amplitudes were quantified at the same timepoints as
for VEP: 30 min, 5 and 28 h and compared to the
baseline condition using one-way ANOVA. P-values
were adjusted using FDR.
RESULTS
Pharmacokinetic profile of sildenafil in rats
Before starting the electrophysiological experiments, we
assessed the pharmacokinetic profile of sildenafil in
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naı¨ve rats to estimate the temporal dynamics of PDE6
inhibition (Fig. 1). Fig. 1A shows the structure of
sildenafil citrate. The total concentrations of sildenafil in
blood and cerebellum were measured at 15 min (Tmax)
and at 5 h after peroral administration of 50 mg/kg
sildenafil, (Fig. 1B). The free unbound brain
concentration of sildenafil at 15 min and 5 h were 817
± 298 nM and 380 ± 159 nM (mean ± STD; n= 4),
respectively. Previously reported half-maximal inhibitory
concentrations (IC50) of PDE6 in cones and rods are
34 nM and 38 nM, respectively (Wallis, 1999). This sug-
gests that PDE6 activity was more than 90% inhibited
up to 5 h after sildenafil
The effect of sildenafil is visualized as the grand
average of VEPs for visual cortex and superior
colliculus, respectively, during the white light condition
(Fig. 1C, D). Seven discernible VEP peaks were
detected in the visual cortex, four positive peaks
denoted P1–4 and three negative peaks denoted N1–3.
Five discernible VEP peaks were detected in the
superior colliculus, 3 positive peaks denoted P1–3 and
two negative peaks denoted N1 and N2. The peak
designation is illustrated in (Fig. S1). Corroborated by
the exposure results showing high concentration of
sildenafil in plasma and brain during EEG recordings
(Fig. 1B), the phototransduction was compromised
following sildenafil administration. Generally, sildenafil
administration increased the peak latency (Figs. 3 and
5) and reduced the amplitudes (Figs. 2 and 4) of the
majority of VEP peaks recorded from the superior
colliculus and visual cortex. The statistical evaluation of
the overall effects of sildenafil are summarized in Tables
S1 and S2 in Supplementary. The statistical evaluation
shows temporal effects following administration of
sildenafil as well as general effects dependent on the
different wavelength conditions. Furthermore,
interactions between the wavelength condition and time
points were observed. In the sections below, the data is
analyzed separately for the three wavelength conditions
using the one-way ANOVA (all ANOVAs are
summarized in Tables S3 and S4 in Supplementary),
the difference of mean is reported if both the ANOVA
and the Tukey post-hoc showed p< 0.05.
Sildenafil-induced changes in VEPs in the visual
cortex
Fig. 2 depicts the amplitudes of the individual VEP peaks
from recordings performed in the visual cortex. Thirty
minutes after administration of sildenafil, there were
statistically significant differences in the amplitudes of
P2, N2 and N3 during stimulation with white light. The
changes in mean amplitude were 0.057, 0.079 and
0.072 mV, respectively for the peaks. At timepoint 5 h,
there were significant differences from the baseline
condition on P2, N2 and N3 (0.067, 0.057 and
0.066 mV, respectively). 28 h after sildenafil
administration there was no detectable changes in
VEPs. In the blue light condition,
the amplitude of the P4 peak was
increased with 0.020 mV after
30 min. After 5 h the P3 was
changed by 0.032 mV, the N3
had was changed by 0.039 mV
in amplitude while the P4 was
increased by 0.186 mV. After
28 h, only the N2 was affected
(amplitude changed by
0.032 mV). In the SWB
condition there was a statistically
significant change in amplitude of
the N3 peak after 30 min
(0.0742 mV) and this effect was
the same after 5 h. The P4 was
modulated throughout all
timepoints (decreased after
30 min; 0.011 mV, decreased after
5 h; 0.013 mV and increased after
28 h; 0.017 mV). Furthermore, the
amplitude of N1 was increased by
0.040 mV while the N2 amplitude
was changed by 0.054 mV.
However, these effects were only
apparent at timepoint 5 h.
The latencies of the waveforms
for the three wavelengths are
depicted in Fig. 3. Thirty minutes
after administration, sildenafil
significantly increased the latency
of all peaks (P1; 0.013 s, N1;
0.023 s, P2; 0.025 s, N2; 0.039 s,
Fig. 1. Effect of sildenafil on visual evoked potentials (VEPs) in rats. (A) Structure of sildenafil citrate.
(B) Total concentration of sildenafil in the plasma and cerebellum. The concentration of unbound
sildenafil is depicted with median and interquartile range. (C, D) Grand average VEP waveforms from
rat visual cortex and superior colliculus, respectively. Waveforms evoked by a 10-ms white-light flash
stimulus are shown at baseline before sildenafil administration (black) and 15 min after (grey) per oral
administration of sildenafil. The broken gray line marks the stimulus flash. More information about
peak designation and the waveforms of steady-state responses can be found in the supplementary
material.
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P3; 0.083 s, N3; 0.096 s and P4; 0.110 s) in the white light
condition. 5 h after drug administration, the latency of the
P1, N1, P3, N3 and P4 components were still increased
(0.014, 0.023, 0.043, 0.056 and 0.058 s, respectively).
In the blue condition the latency of P1, N1, P2, N3 was
increased after 30 min (0.006, 0.0082, 0.006, 0.013 s,
respectively). Effects on P1, N1, P2 and N2 persisted
for 5 h (0.0042, 0.0065, 0.005 and 0.012 s). For the
SWB condition, the latency of the VEP components was
increased for all peaks 30 min after sildenafil
administration (0.016, 0.038, 0.072, 0.093, 0.138, 0.124
and 0.103 s). After 5 h, the differences were still
significant (0.017, 0.028, 0.026, 0.048, 0.097, 0.081 and
0.079 s). No changes from baseline VEPs were
detectable 28 h after sildenafil administration in any of
the wavelength conditions.
Sildenafil-induced changes in VEPs in the superior
colliculus
Grand average VEP waveforms recorded from the
superior colliculus are displayed in Fig. 4. Five
discernible VEP peaks were detected, three positive
peaks denoted P1–3 and two negative peaks denoted
Fig. 2. Sildenafil-induced changes in amplitude of visual evoked potentials from rat visual cortex. Amplitudes are plotted as the mean with standard
error of mean (SEM). The columns depict data obtained from stimulation with different visual stimuli: white, blue and short-wave blue light. The rows
represent time related to dosing: baseline (before dosing), 30 min post, 300 min post, and 28 h after administration of sildenafil. The asterisks refer
to significant differences after sildenafil administration compared to baseline with significance levels of p< 0.05 = *, p< 0.01 = **, and
p< 0.001 = ***.
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N1–2. In the white light condition, there was a statistically
significant change in the amplitude of P1 (0.067 mV)
and an increase in the amplitude of P2 (0.040 mV) after
30 min. After 5 h, the amplitude of P1 was still changed
(0.078 mV). Sildenafil did not affect the amplitude of
the VEP in the blue light condition. For the SWB light
Fig. 3. Sildenafil-induced changes in latency of visual evoked potentials from rat visual cortex. Effects are depicted with mean ± SEM. Latency of
peaks for each time point, for each color: white, blue and short-wave blue light. Asterisks refer to significant differences between baseline and
30 min. Plus signs depicts differences between baseline and 300 min. Significance levels: p< 0.05 =+ and *, p< 0.01 =++ and
**, p< 0.001 =+++ and ***.
Fig. 4. Sildenafil-induced changes in amplitude of visual evoked potentials from rat superior colliculus. The graphs show the mean ± SEM of the
amplitude of peaks under three different color conditions at four timepoints. The columns depict data obtained from stimulation with different visual
stimuli: white, blue and short-wave blue light. The rows represent the four time points: baseline (before dosing), 30 min, 5 h, and 28 h after
administration of sildenafil. The asterisks refer to significant differences after sildenafil administration compared to baseline with significance levels
of p< 0.05 = *, p< 0.01 = **, and p< 0.001 = ***.
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condition, there were statistically significant changes in
the VEP amplitude of P1 and N1 after 30 min (0.061
and 0.057 mV) and 5 h (0.075 and 0.078 mV,
respectively). Furthermore, the P3 was reduced with
0.038 mV after 5 h. After 28 h, there was no detectable
differences in the amplitudes of the VEPs in any light
condition.
Fig. 5 shows the latencies of the VEPs recorded from
the superior colliculus. In the white light condition, the
latency of all peaks was increased 30 min after sildenafil
administration (0.018, 0.038, 0.096, 0.146 and 0.173 s).
These differences were also present after 5 h (0.014,
0.033, 0.044, 0.050 and 0.058 s). In the blue light
condition, sildenafil increased the latency of the early
positive deflections; P1 and P2. The difference of mean
was 0.005 s and 0.012 s, respectively. After 5 h, the
latencies of both peaks were still increased with a
change of 0.006 s and 0.008 s, and the latency of N1
was increased with 0.006 s. In the SWB condition, the
latency of all VEP components were significantly
increased 30 min after sildenafil administration (0.021,
0.034, 0.065, 0.1 and 0.132 s). This effect was also
apparent after 5 h (0.020, 0.028, 0.043, 0.066 and
0.089 s). After 28 h, there was no effect of sildenafil on
the latency of the VEPs in any light condition.
Sildenafil-induced changes in SSVEPs
Representative waveforms of SSVEP are depicted in
Fig. S 2. Both from baseline and 30 min after
administration, from the two sites of recording.
Fig. 6 shows the impact of sildenafil on the SSVEPs
recorded in the visual cortex. In the white light condition,
there were no changes compared to the control
condition in either harmonic. In the blue condition (F
Fig. 5. Sildenafil-induced changes in latency of visual evoked potentials from rat superior colliculus across three color conditions and four time
points. Effects are depicted with mean ± SEM. Asterisks represent differences between baseline and 30 min. Plus signs delineate differences
between control and 300 min. Significance levels: p< 0.05 =+, p< 0.01 =++, and p< 0.001 =+++ and ***.
Fig. 6. Signal-to-noise ratio of the 1st and 2nd harmonic of steady-state visual evoked potentials from visual cortex is affected by sildenafil. The
SNR (mean and ± SEM) of the SSVEP for 1st and 2nd harmonic of the visual cortex during exposure to white, blue and short-wave blue light. The
line plots show time points: 0 = baseline; 30 min after administration of sildenafil, 1, 1.5, 2, 4, 5, 7, 24 and 28 h. The asterisks refer to significant
differences after sildenafil administration compared to baseline with significance levels of p< 0.05 = *, p< 0.01 = **, and p< 0.001 = ***. There
are significant changes for the 1st harmonic of the blue and the SWB conditions.
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(3,25) = 4.57, p= 0.011), the post-hoc test showed that
sildenafil induced a reduction in SNR of the 1st harmonic
30 min after administration (56% decrease relative to
baseline level). After 5 h, the SSVEP SNR was
reduced 47% relative to baseline level. There were no
changes in the 2nd harmonic. In the SWB condition
(F(3,25) = 6.85, p= 0.0032), there was a similar trend
with a statistically significant depression 30 min and 5 h
after administration (57% and 49% reduction,
respectively). As for the blue light condition the SSVEP
was normal after 28 h and there was no effect on the
2nd harmonic.
The SNR of the SSVEP recorded from the superior
colliculus is shown in Fig. 7. Both harmonics were
affected in the white light condition: The 1st harmonic
was significantly affected by sildenafil (F(3,25) = 3.06,
p= 0.047). Here, the SNR was reduced by 36% after
30 min. This effect was not detectable at later
timepoints. Sildenafil also affected the 2nd harmonic (F
(3,25) = 5.76, p= 0.0078). The SNR was decreased
by 31% after 30 min. This effect persisted for 5 h but the
SSVEP was normal after 28 h. In the blue light
condition, there were no changes in the first harmonic.
In the 2nd harmonic there was a statistically significant
(F(3,25) = 6.04, p= 0.0062) depression of the SNR
after 30 min (35%) and after 5 h (22%). The SSVEP
was normalized after 28 h. In the SWB condition, there
was no significant difference in the SNR of the 1st
harmonic between baseline and recordings obtained
from sildenafil-treated rats. For the 2nd harmonic, there
was an increase of the SNR at both 30 min (40%) and
5 h (42%) (F(3,25) = 4.5, p= 0.012). Again, the SNR
was normalized after 28 h.
DISCUSSION
The purpose of the study was to investigate the
progressive effect of PDE6 inhibition on visual
processing by two different electrophysiological assays
following administration of a high-dose sildenafil. The
visual cortex and superior colliculus were both severely
affected by the administration of sildenafil generally
causing reductions in amplitude and increases in latency
of the majority of the VEP peaks. Sildenafil affected
both the superior colliculus and the visual cortex. This
suggests that the compound is primarily impacting early
parts of the visual pathway such as rod and cone
function, as the superior colliculus and the visual cortex
are not part of the same downstream functional pathway
(Sefton et al., 2014). The observed change in the flash
VEPs corresponds well to the observed reductions in
amplitude of a- and b-waves commonly reported from
ERG measurements (Vobig et al., 1999; Nivison-Smith
et al., 2014). Additionally, previous ERG studies evaluat-
ing flicker-ERG responses found prolonged implicit times
for both a- and b-waves (Ja¨gle et al., 2004) which is also
in line with the results of the present study. Studies on
cGMP-specific PDE inhibitors suggest that these effects
may be ascribed to elevated cGMP levels (Estrade
et al., 1998). We did not observe a complete reversal of
the electrophysiological changes after 28 h although
fewer VEP peaks were generally affected at this time-
point. Although sildenafil-induced retinal side effects in
humans are commonly referred to as acute and transient,
our results are supported by sildenafil-induced effects on
ERGs in mice that persisted for at least two days (Nivison-
Smith et al., 2014).
Fig. 7. Signal-to-noise ratio of the 1st and 2nd harmonic of steady-state visual evoked potentials from superior colliculus during exposure to white,
blue and short-wave blue light. The line plots show the mean and ± SEM from each time point: baseline at time = 0 and the last recording at 28 h.
The asterisks refer to significant differences after sildenafil administration compared to baseline with significance levels of p< 0.05 = *,
p< 0.01 = **, and p< 0.001 = ***.
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The superior colliculus receives direct input from the
retina and may thus represent a more ‘clean’ visual
response than EEG recordings obtained from the visual
cortex. This structure does not receive any direct
projections from the retina but integrates information
relayed via other nuclei primarily the dorsolateral
geniculate nucleus (Sefton et al., 2014). Thus, the only
relay that is shared between the two paths is the retina.
Furthermore, EEG was obtained from the visual cortex
using a cortical screw electrode. Consequently, the corti-
cal flash VEPs from this structure may be influenced by
volume conduction from other anatomical areas.
There was a general trend that the profiles of change,
observed in the white light and the SWB conditions, were
similar whereas the blue wavelength condition was
affected to a smaller degree. Interestingly, there was no
detectable change in the amplitude of the VEPs from
the superior colliculus in the blue wavelength condition,
but the latency was significantly increased for the early
peaks, suggesting a partial compensation of the
sildenafil-induced changes.
The exposure after dosing of 50 mg/kg sildenafil
suggests near full inhibition of PDE6 in both rods and
cones up to 5 h after administration of sildenafil. Our
estimate was based on the free unbound brain
concentration, since the physical properties of the
blood–brain barrier and the blood–retinal barrier are
comparable (Toda et al., 2011). The present data are sug-
gestive of a half-life close to 3 h rather than 1 h in female
rats as suggested by Walker et al. (1999). The dose
described in Walker et al. was 1 mg/kg, which is only
2% of the dose used in the current study. This discrep-
ancy could either result from reaching the threshold of
liver enzymes responsible for metabolizing sildenafil or it
could be ascribed to slower absorption.
The inhibitory action of sildenafil on PDE6 is believed
to involve changes in rod and cone outer segment
function along with changes in inner retinal function
(Wallis et al., 1999). Even though PDE6 theoretically
was considered fully inhibited in the present study, the
visual processing was not fully abolished. In common with
other fast-acting enzymes, the function of PDE6 is resis-
tant to complete inhibition and it is challenging to quantify
the level of inhibition necessary to produce visual deficits
(Laties and Zrenner 2002). The catalytic dimer of PDE6
has different forms in rods and cones as it is a heterodi-
mer with two subunits PDE6A and PDE6B in rods, and
a homodimer of PDE6C subunits in cones (Lagman
et al., 2016). Also, different IC50 values are reported for
rods and cones (Wallis, 1999). Thus, it is likely that these
isoforms are not equally inhibited by sildenafil.
In some cases of retinitis pigmentosa, the disease is
caused by mutations in the PDE6 gene (Zhang et al.,
2005). In this disease, the rod cells degenerate first lead-
ing to night blindness at the early stages of the disease
(Hartong et al., 2006). The signal recorded in the visual
cortex after the administration of sildenafil differs from
EEG recordings in rats during dim light conditions (unpub-
lished data), suggesting that the inhibition of PDE6 is not
directly comparable to low-light conditions. Though silde-
nafil inhibits PDE6 in both photoreceptor types, Nivison-
Smith et al. reported that a heterozygous mouse model
of retinitis pigmentosa only showed a limited photorecep-
tor response to the administration of sildenafil compared
to wildtype mice (Nivison-Smith et al., 2014). This sup-
ports that sildenafil and retinitis pigmentosa work by sim-
ilar mechanisms, if the effect of sildenafil is smaller when
PDE6 is already compromised.
Studies have shown that the inhibition of PDE5 may
also contribute to the effect detected. So far, tests to
determine whether sildenafil causes visual adverse
events in humans have been largely restricted to
methods unrelated to electrophysiological assessment.
One rodent study reported ERG effects in mice in line
with the present study, i.e. reduced amplitudes of visual
responses (Nivison-Smith et al., 2014). In humans,
PDE5 inhibition causes increased flow in the ophthalmic
artery (Foresta et al., 2008; Gerometta et al., 2011) and
a similar change in rodents ultimately affecting visual pro-
cessing is not unlikely. Consequently, part of the
sildenafil-induced changes in the visual processing may
be due to increases in intraocular pressure, however,
assuming that changes in pressure affects all photorecep-
tors equally. Then this change does not explain why the
EEG response depends on the wavelength of the stimuli.
This rather confirms the photoreceptors of the retina are
more sensitive to specific wavelengths in the blue part
of the visual spectrum.
In vertebrates, the cascade of linear and non-linear
processing stages in the visual system will convert the
signal frequency associated with periodic full-field
illumination changes into a set of odd- and even-
harmonic response frequencies in the EEG (Regan,
1989). Neurons that respond to overall illumination
changes or neurons with very low spatial frequency pat-
tern sensitivity will contribute to odd harmonics with the
largest response at the input frequency. Neurons that
respond to stimulus changes will generate responses at
both phases of the input, contributing to even harmonics,
with a dominant response at two times the input fre-
quency. It has been suggested that low-frequency
SSVEPs originate early in the visual pathway prior to cor-
tex (Krolak-salmon et al., 2003), and must derive from the
earliest retinal processing stages. As the ipRGCs are light
sensitive, without expressing PDE6 (Hatori and Panda,
2010), this may explain why the second harmonic in
SSVEPs recorded in the visual cortex is not affected in
any of the wavelength conditions; as signal from these
neurons could compensate for the loss of signal from
the photoreceptors. Because of these projections, we
expected the two harmonics from the superior colliculus
to be affected in a comparable manner. In the white light
condition, sildenafil depressed both the first and second
harmonic, as expected. Intriguingly, the ipRGCs have a
peak sensitivity in blue part of the visual spectrum
(480 nm) (Panda et al., 2005). This correlates well with
our results demonstrating a smaller change of VEP and
SSVEP-responses in the blue wavelength (455–460 nm)
condition relative to the others.
Here we demonstrate that translational EEG assays
may be used to study pharmacological-induced changes
in visual processing in rats. In the present study, both
F. G. Østergaard et al. / Neuroscience 441 (2020) 131–141 139
VEPs and the SSVEPs was negatively modulated by
sildenafil which supports the existing literature on ocular
side effects of PDE6 inhibition. The profile of change was
dependent on the wavelength condition, given that the
response to blue light was less affected by sildenafil than
the responses to white or SWB light. VEPs successfully
probed the temporal changes, in this case elucidating a
slowed and weakened visual response, while the
SSVEPs effectively demonstrated effects on the SNR.
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